drug
lenvatinib
updated 5mo agoby Cancer Institute and Hospital Chinese Academy of Medical Sciences
community read0 votes
🐶 often sniffed alongside
top 8- tagOncology20 co-mentions · 3 sources
- companyEisai Co Ltd2 co-mentions · 2 sources
- tagInfectious Disease2 co-mentions · 2 sources
- tagBreast Cancer2 co-mentions · 2 sources
- tagColorectal Cancer2 co-mentions · 2 sources
- tagMelanoma2 co-mentions · 2 sources
- druglenvatinib mesylate2 co-mentions · 2 sources
- companyCancer Institute and Hospital Chinese Academy of Medical Sciences1 co-mentions · 1 sources
all catalysts(1)
Trials studying lenvatinib
- phase2Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients
- —Real-World Lenvatinib Sequencing in Unresectable Hepatocellular Carcinoma (uHCC)
- phase1A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma
- phase3Study Comparing BGB-B2033 With Sorafenib or Lenvatinib in Relapsed Hepatocellular Carcinoma
- phase3Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
- phase1A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
- phase2Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
- phase3Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)
News(1)
- Biomarker-Driven Treatment Decisions and Managing Progression After Frontline ImmunotherapyUpfront biomarker testing reshapes endometrial cancer care, guiding targeted and immune therapy—and exposing gaps in second-line options.onclive · 4mo ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that